Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAltimmune Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 6 | -$0.27 | -$0.22 | -$0.24 |
| Q2 2026 | 6 | -$0.28 | -$0.19 | -$0.24 |
| Q3 2026 | 3 | -$0.27 | -$0.27 | -$0.27 |
| Q4 2026 | 4 | -$0.31 | -$0.31 | -$0.31 |
| Q1 2027 | 2 | -$0.33 | -$0.33 | -$0.33 |
| Q2 2027 | 2 | -$0.35 | -$0.35 | -$0.35 |
| Q3 2027 | 2 | -$0.36 | -$0.36 | -$0.36 |
| Q4 2027 | 2 | -$0.35 | -$0.35 | -$0.35 |
| Q1 2028 | 3 | -$0.37 | -$0.37 | -$0.37 |
| Q2 2028 | 3 | -$0.37 | -$0.37 | -$0.37 |
| Q3 2028 | 3 | -$0.37 | -$0.37 | -$0.37 |
| Q4 2028 | 3 | -$0.36 | -$0.36 | -$0.36 |
Altimmune Inc Earnings Date And Information
Altimmune Inc last posted its earnings results on Thursday, March 5th, 2026. The company reported $-0.27 earnings per share for the quarter, missing analysts' consensus estimates of $-0.25 by $0.02. The company had revenue of 26.00 K for the quarter and had revenue of 41.00 K for the year. Altimmune Inc has generated $-1 earnings per share over the last year ($-1 diluted earnings per share) and currently has a price-to-earnings ratio of -3.52. Altimmune Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Altimmune Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/06/2026 | Q4 2025 | N/A | -$0.27 | N/A | $556 | $26.00 K |
| 11/06/2025 | Q3 2025 | -$0.29 | -$0.21 | 0.08 | $1.43 K | $5.00 K |
| 08/12/2025 | Q2 2025 | -$0.32 | -$0.27 | 0.05 | $1.43 K | $5.00 K |
| 05/13/2025 | Q1 2025 | -$0.35 | -$0.26 | 0.09 | $560 | $5.00 K |
| 02/27/2025 | Q4 2024 | -$0.34 | -$0.33 | 0.01 | $714 | $5.00 K |
| 11/12/2024 | Q3 2024 | -$0.36 | -$0.32 | 0.04 | $714 | $5.00 K |
| 08/08/2024 | Q2 2024 | -$0.34 | -$0.35 | -0.01 | $714 | $5.00 K |
| 05/09/2024 | Q1 2024 | -$0.36 | -$0.34 | 0.02 | $5.00 K | $5.00 K |
| 03/27/2024 | Q4 2023 | -$0.35 | -$0.54 | -0.19 | N/A | $37.00 K |
| 11/07/2023 | Q3 2023 | -$0.40 | -$0.39 | 0.01 | N/A | $362.00 K |
| 08/10/2023 | Q2 2023 | -$0.44 | -$0.32 | 0.12 | N/A | $6.00 K |
| 05/11/2023 | Q1 2023 | -$0.49 | -$0.37 | 0.12 | N/A | $21.00 K |
| 02/28/2023 | Q4 2022 | -$0.52 | -$0.40 | 0.12 | N/A | $-110,000 |
| 11/10/2022 | Q3 2022 | -$0.49 | -$0.48 | 0.01 | N/A | $2.00 K |
| 08/11/2022 | Q2 2022 | -$0.45 | -$0.42 | 0.03 | N/A | $8.00 K |
| 05/12/2022 | Q1 2022 | -$0.57 | -$0.44 | 0.13 | N/A | $32.00 K |
| 03/15/2022 | Q4 2021 | -$0.64 | -$0.57 | 0.07 | N/A | $3.28 M |
| 11/09/2021 | Q3 2021 | -$0.36 | -$0.81 | -0.45 | N/A | $158.00 K |
| 08/10/2021 | Q2 2021 | -$0.44 | -$0.60 | -0.16 | N/A | $137.00 K |
| 05/17/2021 | Q1 2021 | -$0.39 | -$0.38 | 0.01 | N/A | $838.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Altimmune Inc Earnings: FAQ's
The conference call for Altimmune Inc's latest earnings report can be listened to online.
The conference call transcript for Altimmune Inc's latest earnings report can be read online.
Altimmune Inc (:ALT) has a recorded annual revenue of $41.00 K.
Altimmune Inc (:ALT) has a recorded net income of $-88,093,000.Altimmune Inc has generated $-1 earnings per share over the last four quarters.
Altimmune Inc (:ALT) has a price-to-earnings ratio of -3.52 and price/earnings-to-growth ratio is -0.12.